{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:04:24Z","timestamp":1793246664609,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Regional Research Support for Southern Sweden supported this study."},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Epithelial ovarian cancer is usually diagnosed in the advanced stages. To choose the best therapeutic approach, an accurate preoperative assessment of the tumour extent is crucial. This study aimed to determine whether the peritoneal cancer index (PCI), the amount of ascites, and the presence of cardiophrenic nodes (CPLNs) visualized by computed tomography (CT) can assess the tumour extent (S-PCI) and residual disease (RD) for advanced ovarian cancer (AOC) patients treated with upfront surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In total, 118 AOC cases were included between January 2016 and December 2018 at Sk\u00e5ne University Hospital, Lund, Sweden. Linear regression and interclass correlation (ICC) analyses were used to determine the relationship between CT-PCI and S-PCI. The patients were stratified in complete cytoreductive surgery (CCS) with no RD or to non-CCS with RD of any size. The amount of ascites on CT (CT-ascites), CA-125 and the presence of radiological enlarged CPLNs (CT-CPLN) were analysed to evaluate their impact on estimating RD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CT-PCI correlated well with S-PCI (0.397; 95% CI 0.252\u20130.541; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The risk of RD was also related to CT-PCI (OR 1.069 (1.009\u20131.131), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.023) with a cut-off of 21 for CT-PCI (0.715, <jats:italic>p<\/jats:italic>\u2009=\u20090.000). The sensitivity, specificity, positive predictive value and negative predictive value were 58.5, 70.3, 52.2 and 75.4%, respectively. CT-ascites above 1000\u00a0ml predicted RD (OR 3.510 (1.298\u20139.491) <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.013).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CT is a reliable tool to assess the extent of the disease in advanced ovarian cancer. Higher CT-PCI scores and large volumes of ascites estimated on CT predicted RD of any size.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00404-022-06466-8","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T13:02:51Z","timestamp":1646226171000},"page":"1235-1243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC)"],"prefix":"10.1007","volume":"306","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2130-5132","authenticated-orcid":false,"given":"Mihaela","family":"Asp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Malander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils-Olof","family":"Wallengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Pudaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Kannisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"6466_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","volume":"41","author":"PM Webb","year":"2017","unstructured":"Webb PM, Jordan SJ (2017) Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol 41:3\u201314","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"6466_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ygyno.2016.10.039","volume":"144","author":"P Dahm-K\u00e4hler","year":"2017","unstructured":"Dahm-K\u00e4hler P, Borgfeldt C, Holmberg E, Staf C, Falconer H, Bjurberg M, Kj\u00f6lhede P, Rosenberg P, St\u00e5lberg K, H\u00f6gberg T et al (2017) Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin\u2014on behalf of the Swedish gynecological cancer group (SweGCG). Gynecol Oncol 144(1):167\u2013173","journal-title":"Gynecol Oncol"},{"issue":"1","key":"6466_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A (2015) Cancer statistics. CA Cancer J Clin 65(1):5\u201329","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"6466_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177(3):1053\u20131064","journal-title":"Am J Pathol"},{"issue":"10","key":"6466_CR5","first-page":"1156","volume":"20","author":"MS Piver","year":"2006","unstructured":"Piver MS (2006) Treatment of ovarian cancer at the crossroads: 50 years after single-agent melphalan chemotherapy. Oncol (Williston Park) 20(10):1156\u20131158","journal-title":"Oncol (Williston Park)"},{"issue":"6","key":"6466_CR6","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s004230050246","volume":"384","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH (1999) Management of peritoneal-surface malignancy: the surgeon\u2019s role. Langenbecks Arch Surg 384(6):576\u2013587","journal-title":"Langenbecks Arch Surg"},{"key":"6466_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359\u2013374","journal-title":"Cancer Treat Res"},{"issue":"6","key":"6466_CR8","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","volume":"203","author":"RG da Silva","year":"2006","unstructured":"da Silva RG, Sugarbaker PH (2006) Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 203(6):878\u2013886","journal-title":"J Am Coll Surg"},{"issue":"1","key":"6466_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13048-020-00625-8","volume":"13","author":"H Sartor","year":"2020","unstructured":"Sartor H, Bjurberg M, Asp M, Kahn A, Brandstedt J, Kannisto P, Jirstrom K (2020) Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters. J Ovarian Res 13(1):26","journal-title":"J Ovarian Res"},{"issue":"1","key":"6466_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejso.2017.11.003","volume":"44","author":"A Llueca","year":"2018","unstructured":"Llueca A, Escrig J (2018) Prognostic value of peritoneal cancer index in primary advanced ovarian cancer. Eur J Surg Oncol 44(1):163\u2013169","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"6466_CR11","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.acra.2019.04.005","volume":"26","author":"SA Ahmed","year":"2019","unstructured":"Ahmed SA, Abou-Taleb H, Yehia A, El Malek NAA, Siefeldein GS, Badary DM, Jabir MA (2019) The accuracy of multi-detector computed tomography and laparoscopy in the prediction of peritoneal carcinomatosis index score in primary ovarian cancer. Acad Radiol 26(12):1650\u20131658","journal-title":"Acad Radiol"},{"issue":"6","key":"6466_CR12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1080\/0284186X.2017.1409434","volume":"57","author":"S Salehi","year":"2018","unstructured":"Salehi S, Mohammar R, Suzuki C, Joneborg U, Hjerpe E, Torbrand C, Falconer H (2018) Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre\u2014and postoperative imaging. Acta Oncolo (Stockholm, Sweden) 57(6):820\u2013824","journal-title":"Acta Oncolo (Stockholm, Sweden)"},{"issue":"1","key":"6466_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ygyno.2018.11.001","volume":"152","author":"S Prader","year":"2019","unstructured":"Prader S, Vollmar N, du Bois A, Heitz F, Schneider S, Ataseven B, Bommert M, Waltering KU, Heikaus S, Koch JA et al (2019) Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer. Gynecol Oncol 152(1):76\u201381","journal-title":"Gynecol Oncol"},{"issue":"3","key":"6466_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/jcp.2004.018077","volume":"58","author":"EL Moss","year":"2005","unstructured":"Moss EL, Hollingworth J, Reynolds TM (2005) The role of CA125 in clinical practice. J Clin Pathol 58(3):308\u2013312","journal-title":"J Clin Pathol"},{"issue":"2","key":"6466_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1006\/gyno.2000.5749","volume":"77","author":"DS Chi","year":"2000","unstructured":"Chi DS, Venkatraman ES, Masson V, Hoskins WJ (2000) The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol 77(2):227\u2013231","journal-title":"Gynecol Oncol"},{"issue":"2","key":"6466_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/ijgc-00009577-200303000-00003","volume":"13","author":"S Memarzadeh","year":"2003","unstructured":"Memarzadeh S, Lee SB, Berek JS, Farias-Eisner R (2003) CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer 13(2):120\u2013124","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"6466_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000076236","volume":"57","author":"B Obeidat","year":"2004","unstructured":"Obeidat B, Latimer J, Crawford R (2004) Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer? role of preoperative serum CA-125 level. Gynecol Obstet Invest 57(3):153\u2013156","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"6466_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","volume":"145","author":"RS Suidan","year":"2017","unstructured":"Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB, Iyer RB, Zhou Q, Iasonos A, Denesopolis J, Zivanovic O, Long Roche KC et al (2017) A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. Gynecol Oncol 145(1):27\u201331","journal-title":"Gynecol Oncol"},{"key":"6466_CR19","unstructured":"Cancercentrum K. Standardiserad v\u00e5rdf\u00f6rlopp \u00e4ggstockscancer, epitelial 2021 [cited 2021]. Available from: https:\/\/kunskapsbanken.cancercentrum.se\/diagnoser\/aggstockscancer-epitelial\/vardforlopp\/#chapter--Ledtider-for-nationell-uppfoljning."},{"key":"6466_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1477-7819-9-171","volume":"9","author":"CD Duhr","year":"2011","unstructured":"Duhr CD, Kenn W, Kickuth R, Kerscher AG, Germer CT, Hahn D, Pelz JO (2011) Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis. World J Surg Oncol 9:171","journal-title":"World J Surg Oncol"},{"issue":"997","key":"6466_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1259\/bjr\/87415692","volume":"84","author":"SH Chandrashekhara","year":"2011","unstructured":"Chandrashekhara SH, Thulkar S, Srivastava DN, Kumar L, Hariprasad R, Kumar S, Sharma MC (2011) Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer. Br J Radiol 84(997):38\u201343","journal-title":"Br J Radiol"},{"issue":"6","key":"6466_CR22","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A du Bois","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the arbeitsgemeinschaft gynaekologische onkologie studiengruppe ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO). Cancer 115(6):1234\u20131244","journal-title":"Cancer"},{"issue":"8","key":"6466_CR23","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s11547-020-01170-6","volume":"125","author":"G Avesani","year":"2020","unstructured":"Avesani G, Arshad M, Lu H, Fotopoulou C, Cannone F, Melotti R, Aboagye E, Rockall A (2020) Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival. Radiol Med 125(8):770\u2013776","journal-title":"Radiol Med"},{"issue":"1","key":"6466_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12957-018-1339-0","volume":"16","author":"A Llueca","year":"2018","unstructured":"Llueca A, Serra A, Rivadulla I, Gomez L, Escrig J (2018) Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index. World J Surg Oncol 16(1):37","journal-title":"World J Surg Oncol"},{"issue":"1","key":"6466_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1245\/s10434-020-08649-6","volume":"28","author":"B J\u00f3nsd\u00f3ttir","year":"2020","unstructured":"J\u00f3nsd\u00f3ttir B, Lomnytska M, Poromaa IS, Silins I, St\u00e5lberg K (2020) The peritoneal cancer index is a strong predictor of incomplete cytoreductive surgery in ovarian cancer. Ann Surg Oncol 28(1):244\u2013251","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"6466_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nrclinonc.2010.47","volume":"7","author":"S Kyriazi","year":"2010","unstructured":"Kyriazi S, Kaye SB, deSouza NM (2010) Imaging ovarian cancer and peritoneal metastases\u2013current and emerging techniques. Nat Rev Clin Oncol 7(7):381\u2013393","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"6466_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1148\/radiol.2232011081","volume":"223","author":"FV Coakley","year":"2002","unstructured":"Coakley FV, Choi PH, Gougoutas CA, Pothuri B, Venkatraman E, Chi D, Bergman A, Hricak H (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223(2):495\u2013499","journal-title":"Radiology"},{"issue":"5","key":"6466_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bpobgyn.2014.04.006","volume":"28","author":"D Fischerova","year":"2014","unstructured":"Fischerova D, Burgetova A (2014) Imaging techniques for the evaluation of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 28(5):697\u2013720","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"6466_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/IGC.0000000000001173","volume":"28","author":"M Rosendahl","year":"2018","unstructured":"Rosendahl M, Harter P, Bj\u00f8rn SF, H\u00f8gdall C (2018) Specific regions, rather than the entire peritoneal carcinosis index, are predictive of complete resection and survival in advanced epithelial ovarian cancer. Int J Gynecol Cancer 28(2):316\u2013322","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"6466_CR30","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1097\/IGC.0b013e31826a3559","volume":"22","author":"M Luyckx","year":"2012","unstructured":"Luyckx M, Leblanc E, Filleron T, Morice P, Darai E, Classe JM, Ferron G, Stoeckle E, Pomel C, Vinet B et al (2012) Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a retrospective French multicentric Study. Int J Gynecol Cancer 22(8):1337\u20131343","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"6466_CR31","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/ijgc-2019-000682","volume":"29","author":"A Reuss","year":"2019","unstructured":"Reuss A, du Bois A, Harter P, Fotopoulou C, Sehouli J, Aletti G, Guyon F, Greggi S, Mosgaard BJ, Reinthaller A et al (2019) TRUST: trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7). Int J Gynecolo Cancer: Off J Int Gynecol Cancer Soc 29(8):1327\u20131331","journal-title":"Int J Gynecolo Cancer: Off J Int Gynecol Cancer Soc"},{"issue":"5","key":"6466_CR32","first-page":"1319","volume":"19","author":"M Arab","year":"2018","unstructured":"Arab M, Jamdar F, Sadat Hosseini M, Ghodssi-Ghasemabadi R, Farzaneh F, Ashrafganjoei T (2018) Model for prediction of optimal debulking of epithelial ovarian cancer. Asian Pac J Cancer Prev 19(5):1319\u20131324","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"6466_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ygyno.2017.06.008","volume":"146","author":"JB Szender","year":"2017","unstructured":"Szender JB, Emmons T, Belliotti S, Dickson D, Khan A, Morrell K, Khan A, Singel KL, Mayor PC, Moysich KB et al (2017) Impact of ascites volume on clinical outcomes in ovarian cancer: a cohort study. Gynecol Oncol 146(3):491\u2013497","journal-title":"Gynecol Oncol"},{"issue":"1","key":"6466_CR34","first-page":"59","volume":"100","author":"BC Cooper","year":"2002","unstructured":"Cooper BC, Sood AK, Davis CS, Ritchie JM, Sorosky JI, Anderson B, Buller RE (2002) Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer. Obstet Gynecol 100(1):59\u201364","journal-title":"Obstet Gynecol"},{"issue":"1","key":"6466_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/jso.21398","volume":"101","author":"S Kang","year":"2010","unstructured":"Kang S, Kim TJ, Nam BH, Seo SS, Kim BG, Bae DS, Park SY (2010) Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis. J Surg Oncol 101(1):13\u201317","journal-title":"J Surg Oncol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-022-06466-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T09:09:26Z","timestamp":1663060166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-022-06466-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["6466"],"URL":"https:\/\/doi.org\/10.1007\/s00404-022-06466-8","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"5 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflict of interest associated with this article. As corresponding Author, I confirm that the manuscript has been read and approved for submission by all the named authors. Mihaela Asp, MD, PhD student Obstetrics and Gynecology, Department of Clinical Science, Lund University, Lund, Sweden.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patient information was handled according to the Word Medical Association\u00b4s Declaration from the 2008 Declaration of Helsinki and in compliance with national law. This study was approved by the Swedish Ethical Review Authority with apl.no.2019\/00450.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}